Cynosure Lutronic Sets New Standard with eCO2 3D Laser Technology

Published: 06 Oct 2025

Author: Precedence Research

Share :

Cynosure Lutronic, the international market leader in laser and energy-based aesthetic medical technology development, has made a formal announcement concerning the introduction of its new eCO2 3D system. This new next-generation fractional CO2 laser revolutionizes skin resurfacing treatment procedures. The new eCO2 3D is based on an already established company brand, eCO2 Plus, which is well-known in the industry. That offers a rare combination of power, precision, and versatility, making it the most developed CO2 resurfacing technology on the market. The introduction of this innovation marks a turning point in aesthetic medicine, providing practitioners and patients with a more varied treatment process that is safer and more efficient.

CO2 lasers were once regarded as the gold standard for skin rejuvenation, but were associated with several issues, including prolonged recovery times, limited versatility in use, and an increased risk of complications. With the launch of eCO2 3D, Cynosure Lutronic has directly addressed these obstacles. The device offers a variable treatment depth and a combination of scanning spot sizes with an easy-to-use dual delivery mode system. That enables providers to customise each procedure to the unique needs of the patient. Not only has this breakthrough technology brought treatment precision to a whole new level, but it has also enhanced patient comfort and reduced recovery times.

The introduction of the eCO2 3D is also a sign of Cynosure Lutronic's innovation and dedication to keeping pace with the dynamics of the aesthetic market. The demand on medical device manufacturers to enhance the safety and efficacy of their products is increasing, as patients seek non-invasive or minimally invasive solutions for medical conditions that provide visible, long-lasting results. The significance of such technological advances is indescribable in a competitive aesthetic market, where patient expectations continue to grow. Cynosure Lutronic is solidifying its position as a global leader in medical aesthetics by placing a greater emphasis on innovation, safety, and customization.

Executive’s Statement

Chris Aronson, President, North America at Cynosure Lutronic

“CO2 lasers are commonly associated with compromise, whether due to risk, recovery time, or limited treatment flexibility. With the launch of eCO2 3D, we’re proud to offer a solution that addresses those concerns safely and efficiently. We’ve reimagined what a CO2 laser can be. With three scanning spot sizes and two delivery modes within one powerful platform, the eCO2 3D laser offers flexibility and precision for providers, resulting in improved patient outcomes.”